5-(2H-1,3-Benzodioxol-5-yl)-5-methylimidazolidine-2,4-dione

Catalog No. :
ACZEKY395
CAS No. :
308122-40-9
Molecular Formula :
C11H10N2O4
Molecular Weight :
234.21

IUPAC Name:5-(benzo[d][1,3]dioxol-5-yl)-5-methylimidazolidine-2,4-dione

5-(2H-1,3-Benzodioxol-5-yl)-5-methylimidazolidine-2,4-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$84.00Login to see priceInquiryInquiry
100mg95%$121.00Login to see priceInquiryInquiry
250mg95%$163.00Login to see priceInquiryInquiry
1g95%$409.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(2H-1,3-Benzodioxol-5-yl)-5-methylimidazolidine-2,4-dione
IUPAC Name5-(benzo[d][1,3]dioxol-5-yl)-5-methylimidazolidine-2,4-dione
MDL No.MFCD00441460
Molecular FormulaC11H10N2O4
Molecular Weight234.21
SMILESO=C1NC(C(C)(C2=CC=C(OCO3)C3=C2)N1)=O
InChI KeyPTBOGUDVMYIZLL-UHFFFAOYSA-N
Synonym5-(1,3-BENZODIOXOL-5-YL)-5-METHYLIMIDAZOLIDINE-2,4-DIONE;2,4-Imidazolidinedione, 5-(1,3-benzodioxol-5-yl)-5-methyl-;5-(1,3-Benzodioxol-5-yl)-5-methyl-2,4-imidazolidinedione;5-(Benzo[d][1,3]dioxol-5-yl)-5-methyl-2,4-imidazolidinedione
CAS No.308122-40-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZEKY395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZEKY395 route product structure diagram
    ACZEKY395308122-40-9
Inquiry

2. ACZEKY395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZEKY395 route product structure diagram
    ACZEKY395308122-40-9
Inquiry

Comments (0)